Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Iranian Clinical Practice Guideline for Amyotrophic Lateral Sclerosis Publisher



Boostani R1 ; Olfati N1 ; Shamshiri H2, 3 ; Salimi Z4, 5 ; Fatehi F2, 3 ; Hedjazi SA6 ; Fakharian A7, 8, 9 ; Ghasemi M10 ; Okhovat AA2, 3 ; Basiri K10, 11 ; Haghi Ashtiani B12 ; Ansari B10, 11, 13 ; Raissi GR14, 15 ; Khatoonabadi SA16 Show All Authors
Authors
  1. Boostani R1
  2. Olfati N1
  3. Shamshiri H2, 3
  4. Salimi Z4, 5
  5. Fatehi F2, 3
  6. Hedjazi SA6
  7. Fakharian A7, 8, 9
  8. Ghasemi M10
  9. Okhovat AA2, 3
  10. Basiri K10, 11
  11. Haghi Ashtiani B12
  12. Ansari B10, 11, 13
  13. Raissi GR14, 15
  14. Khatoonabadi SA16
  15. Sarraf P17, 18
  16. Movahed S19, 20
  17. Panahi A2, 3
  18. Ziaadini B21, 22
  19. Yazdchi M23, 24
  20. Bakhtiyari J16
  21. Nafissi S2, 3
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Department of Neurology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Department of Psychiatry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran
  7. 7. Pulmonary Rehabilitation Research Center (PRRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  9. 9. Department of Internal Medicine, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  10. 10. Department of Neurology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  11. 11. Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  12. 12. Department of Neurology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  13. 13. AL Zahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  14. 14. Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  15. 15. Neuromusculoskeletal Research Center, Iran University of Medical Sciences, Tehran, Iran
  16. 16. Department of Speech Therapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  18. 18. Department of Neurology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  19. 19. Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  20. 20. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  21. 21. Department of Neurology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  22. 22. Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran
  23. 23. Department of Neurology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  24. 24. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Frontiers in Neurology Published:2023


Abstract

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegeneration involving motor neurons. The 3–5 years that patients have to live is marked by day-to-day loss of motor and sometimes cognitive abilities. Enormous amounts of healthcare services and resources are necessary to support patients and their caregivers during this relatively short but burdensome journey. Organization and management of these resources need to best meet patients' expectations and health system efficiency mandates. This can only occur in the setting of multidisciplinary ALS clinics which are known as the gold standard of ALS care worldwide. To introduce this standard to the care of Iranian ALS patients, which is an inevitable quality milestone, a national ALS clinical practice guideline is the necessary first step. The National ALS guideline will serve as the knowledge base for the development of local clinical pathways to guide patient journeys in multidisciplinary ALS clinics. To this end, we gathered a team of national neuromuscular experts as well as experts in related specialties necessary for delivering multidisciplinary care to ALS patients to develop the Iranian ALS clinical practice guideline. Clinical questions were prepared in the Patient, Intervention, Comparison, and Outcome (PICO) format to serve as a guide for the literature search. Considering the lack of adequate national/local studies at this time, a consensus-based approach was taken to evaluate the quality of the retrieved evidence and summarize recommendations. Copyright © 2023 Boostani, Olfati, Shamshiri, Salimi, Fatehi, Hedjazi, Fakharian, Ghasemi, Okhovat, Basiri, Haghi Ashtiani, Ansari, Raissi, Khatoonabadi, Sarraf, Movahed, Panahi, Ziaadini, Yazdchi, Bakhtiyari and Nafissi.